Advanced Enzyme Technologies Limited has submitted the Exchange a copy of Scrutinizers report of Annual General Meeting held on July 30, 2024.
ADVENZYMES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Advanced Enzyme Technologies Limited held its 36th AGM on July 30, 2025, via video conferencing. All five resolutions were passed with the requisite majority. Key resolutions included adoption of audited standalone and consolidated financial statements for FY25 (99.99% in favour), declaration of a final dividend of Rs. 1.20 per equity share (face value Rs. 2) for FY ended March 31, 2025 (99.99% in favour), re-appointment of Mr. Mukund Kabra as Director (99.88% in favour), appointment of Mr. Shiv Hari Jalan as Secretarial Auditor for five years (99.99% in favour), and approval of related party transactions with subsidiary JC Biotech Private Limited (95.04% in favour, with promoter votes treated as invalid per SEBI norms). Total shareholders on record date were 67,516, with about 64% of outstanding shares voting on most resolutions.
Shareholders have approved a final dividend of Rs. 1.20 per share for FY25, which is positive for income-seeking investors. All routine resolutions passed with overwhelming support, reflecting strong shareholder confidence with no governance red flags.